Company Overview and News

 
ASX closes back over 6000 as banks boost

2017-11-29 theage.com.au
Gains for the big four banks helped the ASX to advance on Wednesday, with the benchmark closing firmly over the key 6000 level for the first time since the middle of November.

 
ASX closes back over 6000 as banks boost

2017-11-29 smh.com.au
Gains for the big four banks helped the ASX to advance on Wednesday, with the benchmark closing firmly over the key 6000 level for the first time since the middle of November.

 
Medicare rebate thaw covers only a fraction of scans

2017-05-16 smh.com.au
The Medicare rebate thaw will not apply to 93 per cent of scans, including the X-rays, MRIs and ultrasounds used to diagnose some of the most common forms of cancer.

 
Enlitic proporciona soluciones de diagnosis de aprendizaje para la Radiological Society Of North America

2016-11-18 prnewswire
SAN FRANCISCO, 18 de noviembre de 2016 /PRNewswire/ -- Enlitic – empresa nueva médica dedicada a la inteligencia artificial de aprendizaje profundo y una de las "50 Smartest Companies" según el MIT Technology Review — se complace en anunciar que los asistentes de la reunión anual de la Radiological Society of North America (RSNA) serán los primeros en ver que la cartera de productos sirve de base para las decisiones clínicas de Enlitic que están impulsadas por la revolucionaria tecnología de aprendizaje profundo.

 
Enlitic aporta soluciones de diagnóstico de aprendizaje profundo a la Sociedad Radiológica de Norteamérica

2016-11-18 prnewswire
SAN FRANCISCO, 17 de noviembre de 2016 /PRNewswire/ -- Enlitic — startup médica de inteligencia artificial de aprendizaje profundo y una de las "50 Smartest Companies" (50 empresas más inteligentes) según el MIT Technology Review — se complace en anunciar que los asistentes de la asamblea anual de la Sociedad Radiológica de Norteamérica (Radiological Society of North America, RSNA) serán los primeros en ver que la cartera de productos sirve de base a las decisiones clínicas de Enlitic impulsadas por tecnología de aprendizaje profundo de avanzada.

 
Enlitic leva soluções para diagnóstico de aprendizado profundo para a Sociedade de Radiologia da América do Norte

2016-11-18 prnewswire
SÃO FRANCISCO, 17 de novembro de 2016 /PRNewswire/ -- A Enlitic – uma startup médica de inteligência artificial de aprendizado profundo e uma das "50 Companhias mais Inteligentes" de acordo com a MIT Technology Review – tem o prazer de anunciar que os participantes do congresso anual da Sociedade de Radiologia da América do Norte (Radiological Society of North America – RSNA) serão os primeiros a ver o portfólio da Enlitic de produtos para suporte a decisões clínicas que utilizam tecnologia de ponta de aprendizado profundo.

 
Enlitic Brings Deep Learning Diagnostic Solutions To The Radiological Society Of North America

2016-11-17 prnewswire
SAN FRANCISCO, Nov. 17, 2016 /PRNewswire/ -- Enlitic – a deep learning artificial intelligence medical startup and one of MIT Technology Review's "50 Smartest Companies" – is pleased to announce that attendees of the annual meeting of the Radiological Society of North America (RSNA) will be the first to see Enlitic's portfolio of clinical decision support products powered by cutting-edge deep learning technology.

 
Capitol Health Ltd appoints Andrew Harrison to the top job

2016-11-14 proactiveinvestors.com.au
Harrison's has experience as a CEO and non-executive director of both publicly listed and proprietary companies, across sectors including healthcare (radiology and dental), resources, and the commercialisation of proprietary intellectual property.

 
How corporate underdogs won on the AFL and NRL's biggest days

2016-10-07 theage.com.au
And so it was last weekend, when the humble Western Bulldogs defeated the Sydney Swans to claim their first AFL grand final in 62 years, and the Cronulla Sharks held off the Melbourne Storm to win its first ever NRL premiership.

 
How corporate underdogs won on the AFL and NRL's biggest days

2016-10-07 smh.com.au
And so it was last weekend, when the humble Western Bulldogs defeated the Sydney Swans to claim their first AFL grand final in 62 years, and the Cronulla Sharks held off the Melbourne Storm to win its first ever NRL premiership.

 
Cronulla Sharks chief sponsor, Capitol Health, in strife

2016-10-06 theage.com.au
The company that owns Cronulla Sharks chief sponsor, Capitol Health, is nursing a major post-premiership hangover with the departure of its chief executive officer just days after the NRL grand final.

 
Cronulla Sharks chief sponsor, Capitol Health, in strife

2016-10-06 smh.com.au
The company that owns Cronulla Sharks chief sponsor, Capitol Health, is nursing a major post-premiership hangover with the departure of its chief executive officer just days after the NRL grand final.

 
NRL grand final 2016: How Cronulla Sharks netted major sponsor via Google search

2016-09-29 smh.com.au
The Sharks' never-ending conga line of major sponsors was solved by a humble Google search from a man who didn't really know who they were – and he is now about to get the type of exposure marketers only dream about.

 
AI Fighter Pilot Beats a Human, But No Need to Panic (Really) | WIRED

2016-06-29 wired
This $3,000 speaker has 4,500 watts of power, can reach 108 decibels, and will destroy your world. bit.ly/2921vXg

 
Capitol Health Ltd to provide diagnostic imaging to China's Sunshine Union Hospital

2016-06-07 proactiveinvestors.com.au
Capitol Health Ltd (ASX:CAJ) will partner with China’s Sunshine Insurance Group to provide tele-radiology services to the 2,000 bed Sunshine Union Hospital in Weifang, Shandong Province, China. The agreement with Sunshine group is part of Capitol’s broader strategy to participate in the Chinese diagnostic imaging market. This provides a platform for Melbourne based Capitol Health to expand its medical diagnostic imaging services, which operates 70 clinics throughout Victoria and New South Wales.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...